Update : August 22, 2008    
Left main coronary
disease
Ostial disease
Bifurcation
Graft vessel disease
Diffuse coronary
disease
Chronic total
occlusion (CTO)
Restenosis
Multivessel disease
Drug eluting stent
Vulnerable plaque
 
State of the Art, Hawaii 2003  

 
• Biodegradable Stents : An update and work-in-progress
- Expert Slide Presentation : Hideo Tamai, M.D, Japan
• New Strategies in the Treatment of AMI
  IS MULTI-VESSEL INTERVENTION REASONABLE IN AMI?
- Expert Slide Presentation : Barry D. Rutherford, MD, USA
• Myocyte Preservation After Mechanical Reperfusion
- Expert Slide Presentation : William W. O’Neill, M.D, USA
• Facilitated Angioplasty in the Treatment of Acute MI
  What is the correct regimen?
- Expert Slide Presentation : Steven P. Marso, MD, USA
• CYPHER vs. TAXUS : TAXUS vs. CYPHER
 
Is there something different ? : Seung-Jung Park, MD, PhD, FACC, Korea
- Focus Review      - Expert Slide Presentation
• The Great Debate
  : All Patients Should Receive a Drug Eluting Stent ?
PRO - Martin Leon, MD
 

|   About summitMD.com   |   Newsletter Archive   |   Submit a Case   |   Contact us   |

Copyright © 2002 CVRF, Seoul, Korea. All rights reserved.